Voloridge Investment Management LLC Invests $1.47 Million in Relx Plc (NYSE:RELX)

Voloridge Investment Management LLC purchased a new stake in Relx Plc (NYSE:RELX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 32,341 shares of the technology company's stock, valued at approximately $1,469,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. LGT Group Foundation purchased a new stake in Relx in the 4th quarter valued at approximately $257,000. Paradigm Asset Management Co. LLC raised its holdings in shares of Relx by 17.1% in the fourth quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company's stock worth $3,706,000 after acquiring an additional 11,900 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Relx by 120.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 12,066 shares of the technology company's stock valued at $548,000 after acquiring an additional 6,588 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Relx by 19.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 143,483 shares of the technology company's stock valued at $6,517,000 after acquiring an additional 23,183 shares during the last quarter. Finally, Hemenway Trust Co LLC increased its position in Relx by 48.2% during the 4th quarter. Hemenway Trust Co LLC now owns 37,260 shares of the technology company's stock worth $1,692,000 after purchasing an additional 12,115 shares in the last quarter. Institutional investors and hedge funds own 15.02% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on RELX shares. Morgan Stanley restated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Wall Street Zen downgraded shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. Finally, The Goldman Sachs Group began coverage on Relx in a research note on Wednesday, March 26th. They set a "buy" rating on the stock. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy".

Relx Trading Up 1.2%

Shares of NYSE RELX traded up $0.63 on Monday, reaching $54.55. 717,214 shares of the company traded hands, compared to its average volume of 720,101. The stock has a market capitalization of $100.70 billion, a PE ratio of 29.33, a P/E/G ratio of 2.73 and a beta of 0.86. Relx Plc has a fifty-two week low of $43.45 and a fifty-two week high of $56.33. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The company has a 50 day moving average of $52.37 and a 200 day moving average of $49.54.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.